Gene-Disorder Association · Article
Gene
CDKN2A Cyclin Dependent Kinase Inhibitor 2A
×
First reported
1994
Supporting publications
76
Manually curated Approved treatment annotated
Association Review
In brief The association between CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) and Melanoma is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.
Sources
2
Clinical variants
3
Symptoms
2
Compounds
7
Trials
323 of 6,385 via CDKN2A compounds
Publications
76
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 2 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
ClinVar and variant evidence
Genetic basis 3 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
06
Population genetics
GWAS signals 2 GWAS phenotypes
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
07
Mechanism overlap
Shared mechanisms 1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
08
Interventions
Therapeutics 7 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
09
Human studies
Clinical trials 6,385 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
76 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
11
Provenance
References & sources 20 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access